Q3 2023 Earnings Presentation
Q3 2023 Surgical
Surgical growth in line with market
+
+
Alcon
Implantables growth led by demand for advanced technology intraocular
lenses in international markets
• Continued ATIOL global and US market leadership
●
●
●
Consumables growth reflects demand for cataract and vitreoretinal
consumables, particularly in international markets, and price increases
Equipment growth compared to strong 2022 base; growth primarily
driven by demand in international markets
-100 bps of negative impact from FX on Surgical growth
1. Constant currency growth is a non-IFRS measure. An explanation of non-IFRS measures can be found in the Appendix.
Net Sales
(USD $M)
$1,216
$392
$618
$206
3Q22
$1,276
$401
$661
$214
3Q23
Implantables
Consumables
Equipment/other
(USD) (CC)¹
5%
2%
4%
6%
7% 7%
9
5%
5%View entire presentation